Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Keenan RJ et al. |
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. |
1991 |
Transplantation |
pmid:1719668
|
Rosen HR et al. |
Significance of early aminotransferase elevation after liver transplantation. |
1998 |
Transplantation |
pmid:9448146
|
McCune TR et al. |
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. |
1998 |
Transplantation |
pmid:9448150
|
Schwartz JJ et al. |
Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. |
2007 |
Transplantation |
pmid:17893604
|
Mentzer RM et al. |
Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group. |
1998 |
Transplantation |
pmid:9448154
|
Andrades KM et al. |
Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. |
2013 |
Transplantation |
pmid:23380869
|
Tydén G et al. |
Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations. |
2007 |
Transplantation |
pmid:17496528
|
Faguer S et al. |
Rituximab therapy for acute humoral rejection after kidney transplantation. |
2007 |
Transplantation |
pmid:17496547
|
Khanna A et al. |
Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. |
1998 |
Transplantation |
pmid:9500620
|
Gayowski T et al. |
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. |
1998 |
Transplantation |
pmid:9500623
|
Neylan JF |
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9500626
|
Rodrigo E et al. |
Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development. |
2016 |
Transplantation |
pmid:26703349
|
Pescovitz MD et al. |
Prospective observational study of sirolimus as primary immunosuppression after renal transplantation. |
2009 |
Transplantation |
pmid:19855247
|
Miroux C et al. |
In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function. |
2012 |
Transplantation |
pmid:22743548
|
D'Antiga L et al. |
Late cellular rejection in paediatric liver transplantation: aetiology and outcome. |
2002 |
Transplantation |
pmid:11792983
|
Butani L et al. |
Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient. |
2002 |
Transplantation |
pmid:11793001
|
David-Neto E et al. |
The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients. |
2007 |
Transplantation |
pmid:17627237
|
Murase N et al. |
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. |
1990 |
Transplantation |
pmid:1696405
|
Leung W et al. |
Long-term complete remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders complicating liver transplant. |
1999 |
Transplantation |
pmid:10385092
|
Propper DJ et al. |
FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions. |
1990 |
Transplantation |
pmid:1696409
|
Maruyama M et al. |
Effect of FK506 treatment on allocytolytic T lymphocyte induction in vivo: differential effects of FK506 on L3T4+ and Ly2+ T cells. |
1990 |
Transplantation |
pmid:1696410
|
Larsen JL et al. |
Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. |
2006 |
Transplantation |
pmid:16926589
|
Roy A et al. |
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. |
2006 |
Transplantation |
pmid:16926593
|
Xue F et al. |
Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. |
2010 |
Transplantation |
pmid:20010326
|
Welberry Smith MP et al. |
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial. |
2013 |
Transplantation |
pmid:24056618
|
Ciancio G et al. |
Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. |
2002 |
Transplantation |
pmid:11965039
|
Petruzzo P et al. |
The International Registry on Hand and Composite Tissue Transplantation. |
2010 |
Transplantation |
pmid:21052038
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Kessler M et al. |
A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. |
1999 |
Transplantation |
pmid:10071045
|
de Graav GN et al. |
A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation. |
2017 |
Transplantation |
pmid:28403127
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Tabasco-Minguillan J et al. |
Insulin requirements after liver transplantation and FK-506 immunosuppression. |
1993 |
Transplantation |
pmid:7692637
|
Wang SC et al. |
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells. |
1993 |
Transplantation |
pmid:7692640
|
Guo Z et al. |
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. |
1997 |
Transplantation |
pmid:9075844
|
Watanabe M et al. |
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. |
2013 |
Transplantation |
pmid:23860082
|
Zhao WY et al. |
Single kidneys transplanted from small pediatric donors less than 15 kilograms into pediatric recipients. |
2014 |
Transplantation |
pmid:25955345
|
Lenaers JI et al. |
Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. |
2006 |
Transplantation |
pmid:17102764
|
van Rijen MM et al. |
CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. |
2002 |
Transplantation |
pmid:12042657
|
Yamamoto S et al. |
FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation. |
2004 |
Transplantation |
pmid:15591950
|
Tan HP et al. |
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. |
2004 |
Transplantation |
pmid:15591960
|
Lang T et al. |
Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. |
1996 |
Transplantation |
pmid:8824477
|
Bäckman L et al. |
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. |
1994 |
Transplantation |
pmid:7509516
|
Mahé E et al. |
Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. |
2004 |
Transplantation |
pmid:14966435
|
Paramesh AS et al. |
Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. |
2004 |
Transplantation |
pmid:14724447
|
Gallon L et al. |
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. |
2006 |
Transplantation |
pmid:16477235
|
Boillot O et al. |
Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation: a pilot study. |
1998 |
Transplantation |
pmid:9825815
|
Sanchez EQ et al. |
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. |
2010 |
Transplantation |
pmid:20098288
|
Moreau C et al. |
Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient. |
2006 |
Transplantation |
pmid:16477241
|
Jain AB et al. |
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. |
1998 |
Transplantation |
pmid:9825817
|
Franz M et al. |
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? |
1998 |
Transplantation |
pmid:9825827
|
Niioka T et al. |
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation. |
2012 |
Transplantation |
pmid:23073468
|
Guerville F et al. |
Transplantation with pathologic kidneys to improve the pool of donors: an example of shunt nephritis. |
2012 |
Transplantation |
pmid:22487813
|
Mathis AS et al. |
Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors. |
2001 |
Transplantation |
pmid:11374405
|
Swinnen LJ et al. |
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. |
2008 |
Transplantation |
pmid:18645482
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Wannhoff A et al. |
Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. |
2014 |
Transplantation |
pmid:25022236
|
Sureshkumar KK and Chopra B |
In search of an optimal induction agent in kidney transplantation. |
2014 |
Transplantation |
pmid:24978038
|
Welberry Smith MP and Baker RJ |
The author's reply. |
2014 |
Transplantation |
pmid:24978039
|
Singla AK et al. |
Cerulomycin Caerulomycin [corrected] A: a potent novel immunosuppressive agent. |
2014 |
Transplantation |
pmid:24949498
|
Srinivas TR et al. |
The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. |
2005 |
Transplantation |
pmid:16251854
|
Walsh C et al. |
Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients. |
2013 |
Transplantation |
pmid:23296149
|
Buell JF et al. |
Malignancy after transplantation. |
2005 |
Transplantation |
pmid:16251858
|
Hariharan S |
Case 2: strategies to minimize the use of calcineurin inhibitors (CNIs). |
2002 |
Transplantation |
pmid:12357988
|
Zaltzman JS |
A comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily cyclosporine on renal function in healthy volunteers. |
2010 |
Transplantation |
pmid:21166111
|
Stempfle HU et al. |
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. |
2002 |
Transplantation |
pmid:11889427
|
Randhawa PS et al. |
Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization. |
1999 |
Transplantation |
pmid:9921801
|
Taylor-Fishwick DA et al. |
Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use. |
1993 |
Transplantation |
pmid:7689258
|
Shaefer MS et al. |
Falsely elevated FK-506 levels caused by sampling through central venous catheters. |
1993 |
Transplantation |
pmid:7689264
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Oike F et al. |
A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. |
2000 |
Transplantation |
pmid:10868630
|
Gloor JM et al. |
Subclinical rejection in tacrolimus-treated renal transplant recipients. |
2002 |
Transplantation |
pmid:12131699
|
Aw MM et al. |
Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience. |
2003 |
Transplantation |
pmid:12660504
|
Charpentier B et al. |
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. |
2003 |
Transplantation |
pmid:12660513
|
Anil Kumar MS et al. |
Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. |
2005 |
Transplantation |
pmid:16210969
|
van Boekel GA et al. |
Effect of mild diarrhea on tacrolimus exposure. |
2012 |
Transplantation |
pmid:22955188
|
Ellis D et al. |
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. |
2007 |
Transplantation |
pmid:17589338
|
Farley DE et al. |
The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. |
1991 |
Transplantation |
pmid:1713360
|
Webb NJ et al. |
Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. |
2015 |
Transplantation |
pmid:25539467
|
Yoo MC et al. |
Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients. |
2015 |
Transplantation |
pmid:25539464
|
Pirenne J et al. |
Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model. |
1996 |
Transplantation |
pmid:8685944
|
Tsugita M et al. |
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. |
1996 |
Transplantation |
pmid:8685952
|
Brito-Costa A et al. |
Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents. |
2016 |
Transplantation |
pmid:27136260
|
Gruessner RW et al. |
Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation. |
2004 |
Transplantation |
pmid:15239611
|
Gralla J and Wiseman AC |
The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression. |
2010 |
Transplantation |
pmid:20595929
|
Glotz D et al. |
Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids. |
2010 |
Transplantation |
pmid:20386144
|
Margreiter R et al. |
A double-hand transplant can be worth the effort! |
2002 |
Transplantation |
pmid:12134104
|
Tian L et al. |
Association of the CD134/CD134L costimulatory pathway with acute rejection of small bowel allograft. |
2002 |
Transplantation |
pmid:12134113
|
Opelz G and Döhler B |
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. |
2011 |
Transplantation |
pmid:21452411
|
Veenhof H et al. |
Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients. |
2017 |
Transplantation |
pmid:27906832
|
Jin L et al. |
Effect of Conversion to CTLA4Ig on Tacrolimus-Induced Diabetic Rats. |
2018 |
Transplantation |
pmid:29319618
|
Miura Y et al. |
Factors increasing quantitative interstitial fibrosis from 0 hr to 1 year in living kidney transplant patients receiving tacrolimus. |
2011 |
Transplantation |
pmid:21452412
|
MacPhee IA and Holt DW |
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. |
2008 |
Transplantation |
pmid:18212618
|
Cezário ES et al. |
Gingival overgrowth in renal transplant subjects medicated with tacrolimus in the absence of calcium channel blockers. |
2008 |
Transplantation |
pmid:18212628
|
Rayar M et al. |
High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes. |
2018 |
Transplantation |
pmid:29315140
|
Gillard P et al. |
Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts. |
2008 |
Transplantation |
pmid:18212631
|
Tourret J et al. |
Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli. |
2017 |
Transplantation |
pmid:27681266
|
Kuypers DR et al. |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. |
2006 |
Transplantation |
pmid:16794545
|
Wiesner RH |
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. |
1998 |
Transplantation |
pmid:9734494
|
Hodak SP et al. |
QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. |
1998 |
Transplantation |
pmid:9734501
|